STOCK TITAN

Monro, Inc. (MNRO) director Lindsay Hyde granted 11,149 restricted shares

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Hyde Lindsay reported acquisition or exercise transactions in this Form 4 filing.

Monro, Inc. reported that director Lindsay Hyde received a grant of 11,149 shares of Common Stock as a restricted stock award under the company’s Amended and Restated 2007 Stock Incentive Plan. The award vests one-third on each of the first three anniversaries of the grant date, bringing Hyde’s direct holdings to 41,877 shares.

Positive

  • None.

Negative

  • None.
Insider Hyde Lindsay
Role Director
Type Security Shares Price Value
Grant/Award Common Stock F1 11,149 $0.00 $0.00
Holdings After Transaction: Common Stock — 41,877 shares (Direct)
Footnotes (1)
  1. F1. This award of restricted stock is granted under the Company's Amended and Restated 2007 Stock Incentive Plan (the "Plan") and vests one-third on each of the three anniversaries of the grant date.
Restricted stock granted 11,149 shares Grant of Common Stock to director Lindsay Hyde on 2026-08-11
Price per share $0.00 Stated per-share price for the restricted stock award
Shares owned after transaction 41,877 shares Total direct Common Stock holdings of Lindsay Hyde after the award
Vesting schedule 1/3 each year over 3 years Restricted stock vests one-third on each of the three anniversaries of grant date
restricted stock financial
"This award of restricted stock is granted under the Company's Amended and Restated 2007 Stock Incentive Plan"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
Amended and Restated 2007 Stock Incentive Plan financial
"granted under the Company's Amended and Restated 2007 Stock Incentive Plan (the "Plan")"
vests one-third on each of the three anniversaries financial
"and vests one-third on each of the three anniversaries of the grant date"

FAQ

What insider transaction did Monro, Inc. (MNRO) report for Lindsay Hyde?

Monro, Inc. reported that director Lindsay Hyde received a grant of 11,149 shares of Common Stock as a restricted stock award under the company’s Amended and Restated 2007 Stock Incentive Plan.

Is the recent MNRO insider transaction a purchase or a grant?

The MNRO insider transaction is a grant/award acquisition, not an open-market purchase. Director Lindsay Hyde received 11,149 restricted shares at a stated price of $0.00 per share as equity compensation.

How many Monro (MNRO) shares does Lindsay Hyde hold after the award?

Following the reported grant, Lindsay Hyde directly holds 41,877 shares of Monro Common Stock. This figure includes the newly awarded 11,149 restricted shares, which are subject to a time-based vesting schedule.

What is the vesting schedule for Lindsay Hyde’s restricted stock in MNRO?

The 11,149 restricted shares granted to Lindsay Hyde vest one-third on each of the three anniversaries of the grant date. Full vesting therefore occurs over a three-year period, subject to continued service and plan terms.

Under which plan was the recent MNRO restricted stock granted?

The restricted stock was granted under Monro’s Amended and Restated 2007 Stock Incentive Plan. This plan governs equity compensation awards such as restricted stock and provides the terms for vesting and other conditions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hyde Lindsay

(Last)(First)(Middle)
295 WOODCLIFF DRIVE
SUITE 202

(Street)
FAIRPORT NEW YORK 14450

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
MONRO, INC. [ MNRO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/11/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/11/2026A11,149(1)A$0.0041,877D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. This award of restricted stock is granted under the Company's Amended and Restated 2007 Stock Incentive Plan (the "Plan") and vests one-third on each of the three anniversaries of the grant date.
/s/ Lindsay Hyde08/11/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)